美股異動｜擬發行20億美元可轉換高級票據，Moderna（MRNA.US）跌超5%

According to Jinse Finance's APP, on Thursday, Moderna (MRNA.US) opened lower and continued to decline. As of press time, its drop exceeded 5%, with a market capitalization of approximately $56.6 billion. In terms of news, Moderna will issue $2 billion worth of convertible senior notes. Previously, Moderna and Merck jointly announced that their co-developed personalized cancer vaccine, intismeran, combined with Keytruda (pembrolizumab), achieved both recurrence-free survival (RFS) and distant metastasis-free survival (DMFS) primary endpoints in the phase III INTerpath-001 trial for completely resected stage IIB to IV melanoma. Over the past week, the stock has recorded an increase of nearly 130%.